{"product_id":"international-neurology-isbn-9781118777367","title":"International Neurology","description":"This unique textbook deals with the variations in the causes, presentations and treatment of neurological disease throughout human populations. \u003ci\u003eInternational Neurology\u003c\/i\u003e is an indispensable guide to the full range of neurological conditions you will see in your ever-changing patient population.\u003cbr\u003e \u003cul\u003e \u003cli\u003eComprehensive coverage of neurological diseases and disorders with a clinical approach to diagnosis, treatment and management\u003c\/li\u003e \u003cli\u003eTruly international authorship distils expert knowledge from around the world\u003c\/li\u003e \u003cli\u003eSuccinct, bite-sized, templated chapters allow for rapid clinical referral\u003c\/li\u003e \u003cli\u003eFurther reading recommendations for each chapter guide readers requiring more depth of information\u003c\/li\u003e \u003cli\u003eEndorsed by the World Federation of Neurology\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eList of contributors\u003c\/p\u003e \u003cp\u003eForeword\u003c\/p\u003e \u003cp\u003eEndorsement from the World Federation of Neurology\u003c\/p\u003e \u003cp\u003ePreface\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1 Vascular\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Overview of Stroke\u003cbr\u003e\u003ci\u003eChristopher Li-Hsian Chen, Chung Y. Hsu\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Ischemic Stroke and Transient Events, TIA\u003cbr\u003e\u003ci\u003eLidia Yamada, Shelly Ozark, Bruce Ovbiagele\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Atherothrombotic Disease\u003cbr\u003e\u003ci\u003eNijasri C. Suwanwela\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Occlusion Disease of Small Penetrating Arteries\u003cbr\u003e\u003ci\u003eMarie Dagonnier, Takeshi Iwanaga, Hock L. Teoh, Jorge A. Zavala, Geoffrey A. Donann\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Ischemic White Matter Disease (Binswanger’s disease)\u003cbr\u003e\u003ci\u003eSaltanat U. Kamenova, Aida M. Kondybayeva, Assiya Akanova\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Brain Embolism\u003cbr\u003e\u003ci\u003eBernard P. L. Chan, N. Venketasubramanian, Chung Y. Hsu\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Systemic Hypotensive Injury (Border Zone Infarction)\u003cbr\u003e\u003ci\u003eThomas W. Leung\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Dissection of the Cervicocerebral Arteries\u003cbr\u003e\u003ci\u003eNijasri C. Suwanwela\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Coagulation Disorders\u003cbr\u003e\u003ci\u003eKay Sin Tan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Hemorrhagic Strokes\u003cbr\u003e\u003ci\u003eAnna Katharina Flügel, Thorsten Steiner, Josef Schill, Nauman Jahangir, Morad Chughtai, Mushtaq H. Qureshi, Adnan I. Qureshi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Strokes in Children and Young Adults\u003cbr\u003e\u003ci\u003eAlfred Lindner, Ute Berweiler\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Other Cerebrovascular Syndromes\u003cbr\u003e\u003ci\u003eDavid J. Blacker\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Cerebral Venous Disease\u003cbr\u003e\u003ci\u003ePatrick W. Carney, Stephen M. Davis\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Spinal Cord Strokes\u003cbr\u003e\u003ci\u003eRohini Bhole, Louis R. Caplan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2 Disorders of Cerebrovacular Autonomic Control\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e15 Reversible Cerebral Vasoconstrictive Syndrome (RCVS)\u003cbr\u003e\u003ci\u003eShih-Pin Chen, Shuu-Jiun Wang\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Posterior Reversible Encephalopathy Syndrome (PRES)\u003cbr\u003e\u003ci\u003ePratik Bhattacharya\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3 The Vasculitides\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eInflammatory vasculopathy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Extracranial and Intracranial Granulomatous Arteritis (Giant cell arteritis)\u003cbr\u003e\u003ci\u003eGregory P. Van Stavern\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Intracranial granulomatous Arteritis (primary Angiitis of the CNS)\/ Idiopathic CNS Vasculitis\u003cbr\u003e\u003ci\u003eDonald Silberberg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Takayasu’s Arteritis\u003cbr\u003e\u003ci\u003eYasuhisa Kitagawa\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Polyarteritis Nodosa, Churg-Strauss and Overlap Vasculitis Syndrome\u003cbr\u003e\u003ci\u003eArnold I. Levinson, Robert P Lisak\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Granulomatosis with Polyangiitis (GPS)\u003cbr\u003e\u003ci\u003eGerard Said\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Cerebrovascular Disease Associated with Antiphospholipid Antibody\u003cbr\u003e\u003ci\u003eAdrian Marchidann, Steven R. Levine\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Thromboangiitis Obliterans – Buerger disease\u003cbr\u003e\u003ci\u003eKumar Rajamani\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Susac’s disease\u003cbr\u003e\u003ci\u003eRachel E. Ventura, Steven L. Galetta\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 4 Inflammatory Vasculopathies\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e25 SLE, Rheumatoid arthritis, Sjögren’s syndrome\u003cbr\u003e\u003ci\u003eMarc Gotkine, Oded Abramsky\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26 Progressive Systemic Sclerosis\u003cbr\u003e\u003ci\u003eHo Jin Kim, Jae-Won Hyun\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 Mixed connective tissue disorders\u003cbr\u003e\u003ci\u003eHo Jin Kim, Jae-Won Hyun\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28 Micro vasculitides and Behcet’s disease\u003cbr\u003e\u003ci\u003eUgur Uygunoglu, Sabahattin Saip, Aksel Siva\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e29 Sarcoidosis\u003cbr\u003e\u003ci\u003eBarney J. Stern\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30 Autoimmune Encephalitis with Neuronal Cell Surface Antibodies\u003cbr\u003e\u003ci\u003eJosep Dalmau, Myrna R. Rosenfeld\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 5 Paroxysmal disorders\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e31 Epilepsy Overview\u003cbr\u003e\u003ci\u003eAndres M. Kanner, Barbara E. Swartz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e32 Cryptogenic and Symptomatic Generalized Epilepsies and Syndromes\u003cbr\u003e\u003ci\u003eMarco T. Medina, Antonio V. Delgado-Escueta, Luis C. Rodríguez Salinas, Marco Medina-Montoya, Barbara E Swartz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e33 Genetic (primary) Idiopathic Generalized Epilepsies\u003cbr\u003e\u003ci\u003eAfawi Zaid, Altynshash Jaxybayeva\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 Localization Related Epilepsies\u003cbr\u003e\u003ci\u003eHirokazu Oguni, Chrysostomos P. Panayiotopoulos\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35 Neurodiagnostic Tools for the Paroxysmal Disorders\u003cbr\u003e\u003ci\u003eBarbara E. Swartz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36 Neuropharmacology of Antiepileptic Drugs\u003cbr\u003e\u003ci\u003ePaul B. Pritchard, III\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e37 Surgical and Other Treatment\u003cbr\u003e\u003ci\u003eIvan Rektor, Barbara E. Swartz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 6 Dementia\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e38 Dementia Overview\u003cbr\u003e\u003ci\u003eMurray Grossman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e39 Mild cognitive impairment to include amnestic mild cognitive impairment and Alzheimer’s disease\u003cbr\u003e\u003ci\u003eDavid Wolk, Sanjeev Vaishnavi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e40 Parkinson's Dementia, Lewy Body Disease and Other Synucleinopathies\u003cbr\u003e\u003ci\u003eIrena Rektorová, Marek Baláž, Robert Rusina, Radoslav Matìj\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e41 Specific Vascular Syndromes\u003cbr\u003e\u003ci\u003eElka Stefanova, Vladimir Kostiæ\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e42 Vascular cognitive Impairment\u003cbr\u003e\u003ci\u003eElka Stefanova, Vladimir Kostiæ\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e43 Frontotemporal dementia\u003cbr\u003e\u003ci\u003eKatya Rascovsky, Diana Matallana\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e44 Progressive Supranuclear Palsy, Corticobasal Syndrome and Other Tauopathies\u003cbr\u003e\u003ci\u003eDavid J. Irwin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e45 Amyotrophic Lateral Sclerosis and Other TDP-43 Proteinopathies\u003cbr\u003e\u003ci\u003eAlbert C. Ludolph\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e46 Metabolic, toxic, infectious, inflammatory and other dementias\u003cbr\u003e\u003ci\u003eJohn M. Ringman, Arousiak Varpetian, Yu-Wei Lin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 7 Movement Disorders\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e47 Movement disorders: An overview\u003cbr\u003e\u003ci\u003eRoongroj Bhidayasiri, Jirada Sringean, Daniel D. Truong\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e48 Tremor\u003cbr\u003e\u003ci\u003eJan Raethjen, Günther Deuschl\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e49 Parkinsonism\u003cbr\u003e\u003ci\u003eDronacharya Lamichhane, Lisa M. Shulman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e50 Parkinson’s disease\u003cbr\u003e\u003ci\u003eDaniel D. Truong, Roongroj Bhidayasiri\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e51 Dystonia\u003cbr\u003e\u003ci\u003eStanley Fahn\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e52 Chorea and related disorders\u003cbr\u003e\u003ci\u003eRoongroj Bhidayasiri, Onanong Jitkritsadakul, Daniel D. Truong\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e53 Myoclonus\u003cbr\u003e\u003ci\u003eJohn N. Caviness, Daniel D. Truong\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e54 Tics and Tourette syndrome\u003cbr\u003e\u003ci\u003eValerie Suski, Mark Stacy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e55 Ataxia\u003cbr\u003e\u003ci\u003eSergey N. Illarioshkin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e56 Drug induced movement disorders\u003cbr\u003e\u003ci\u003eRick Stell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e57 Paroxysmal movement disorders\u003cbr\u003e\u003ci\u003eSopio Sopromadze, Alexander Tsiskaridze\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 8 Infectious diseases\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eBacterial infections\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e58 Acute bacterial meningitis\u003cbr\u003e\u003ci\u003eSudesh Prabhakar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e59 Brain abscess\u003cbr\u003e\u003ci\u003eGagandeep Singh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e60 Subdural empyema\u003cbr\u003e\u003ci\u003eSandi Lam, Eric Momin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e61 Epidural abscess\u003cbr\u003e\u003ci\u003eSandi Lam, Humphrey Okechi, Jared Fridley\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e62 Intracranial septic thrombophlebitis\u003cbr\u003e\u003ci\u003eIsmail A. Khatri, Mohammad Wasay\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e63 Encephalitis due to bacterial infections\u003cbr\u003e\u003ci\u003eKaren L. Roos, Jennifer Durphy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eMycobacterial infections\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e64 Mycobacterium tuberculosis and avium\u003cbr\u003e\u003ci\u003eEinar P. Wilder-Smith\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e65 Leprosy\u003cbr\u003e\u003ci\u003eMinh Le, Minh Hoang Van\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eSpirochetal infections\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e66 Neurosyphilis\u003cbr\u003e\u003ci\u003eJonathan Carr\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e67 Lyme disease\u003cbr\u003e\u003ci\u003ePatricia K. Coyle\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eProtozoan diseases\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e68 Introduction to protozoans of the central nervous system\u003cbr\u003e\u003ci\u003eMarylou V. Solbrig\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e69 Amoebic disease of the central nervous system\u003cbr\u003e\u003ci\u003eMelanie Walker\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e70 Toxoplasmosis of the central nervous system\u003cbr\u003e\u003ci\u003eMarylou V. Solbrig\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e71 Cerebral malaria\u003cbr\u003e\u003ci\u003ePolrat Wilairatana, Srivicha Krudsood, Noppadon Tangpukdee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e72 Trypanosomiasis\u003cbr\u003e\u003ci\u003eFrancisco Javier Carod-Artal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eHelminthic\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e73 Cestodes\u003cbr\u003e\u003ci\u003eOscar H. Del Brutto\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e74 Trematodes: schistosomiasis\u003cbr\u003e\u003ci\u003eManjari Tripathi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e75 Nematodes\u003cbr\u003e\u003ci\u003eManjari Tripathi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eOther infection\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e76 Fungal infections of the central nervous system\u003cbr\u003e\u003ci\u003eThomas Cesario\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e77 Rickettsial disease\u003cbr\u003e\u003ci\u003eKelly J Baldwin, Narendra Rathi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 9 Prion diseases and Neurovirology\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e78 Prion Disorders\u003cbr\u003e\u003ci\u003eEllen Gelpi, Herbert Budka\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e79 Acute and recurrent viral meningitis\u003cbr\u003e\u003ci\u003eLarry E. Davis\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e80 Acute viral encephalitis\u003cbr\u003e\u003ci\u003eHeng Thay Chong, Chong Tin Tan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e81 Neurologic complications of human herpes virus infections\u003cbr\u003e\u003ci\u003eDon Gilden, Maria A. Nagel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e82 Chronic viral diseases of the CNS\u003cbr\u003e\u003ci\u003eMaria A. Nagel, Don Gilden\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e83 Progressive multifocal leukoencephalopathy, PML\u003cbr\u003e\u003ci\u003eSalim Chahin, Thomas Weber, Joseph R. Berger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eHIV and the Nervous System\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e84 Biology of the HIV Virus and overview of AIDS\u003cbr\u003e\u003ci\u003eAlexandros C. Tselis\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e85 HIV encephalitis and myelopathy\u003cbr\u003e\u003ci\u003eGirish Modi, Kapila Hari, Andre Mochan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e86 Neuromuscular complications of HIV\u003cbr\u003e\u003ci\u003eDavid M. Simpson, Kara Stavros\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e87 Opportunistic Infections in HIV Positive Subjects and AIDS patients\u003cbr\u003e\u003ci\u003eB. J. Brew, A. Laffan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e88 Neurologic Complications of HTLV-1\u003cbr\u003e\u003ci\u003eAbelardo Q-C Araujo, Marco A. Lima, Marcus Tulius Silva\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 10 Demyelinating Disorders\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e89 Multiple sclerosis\u003cbr\u003e\u003ci\u003eRobert P. Lisak, Jun-Ichi Kira\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e90 Multiple sclerosis in children\u003cbr\u003e\u003ci\u003eSarah E. Hopkins, Yael Hacohen, Sona Narula, Brenda L Banwell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e91 Neuromyelitis optica\u003cbr\u003e\u003ci\u003eWilliam M. Carroll\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e92 Acute disseminated encephalomyelitis\u003cbr\u003e\u003ci\u003eSona Narula, Sarah E. Hopkins, Yael Hacohen, and Brenda Banwell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e93 Isolated inflammatory demyelinating CNS syndromes\u003cbr\u003e\u003ci\u003eErnest Willoughby\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e94 Osmotic demyelination syndromes\u003cbr\u003e\u003ci\u003eOvidiu-Alexandru Bajenaru\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e95 Concentric sclerosis\u003cbr\u003e\u003ci\u003eTakeshi Tabira\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 11 Specific toxicities and deficiencies\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e96 Toxicology\u003cbr\u003e\u003ci\u003eChin-Chang Huang, Nai-Shin Chu\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e97 Alcohol related neurological disorders\u003cbr\u003e\u003ci\u003eYuri Alekseenko\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e98 Vitamin Deficiencies\u003cbr\u003e\u003ci\u003eJacques Serratrice, Volodymyr Golyk\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e99 Starvation, Strachan syndrome and postgastroplasty syndrome\u003cbr\u003e\u003ci\u003eIvan Milanov, Vesselina Grozeva\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 12 Peripheral Neuropathies\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e100 Peripheral Neuropathies overview\u003cbr\u003e\u003ci\u003eFriedhelm Sandbrink\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e101 Hereditary neuropathies\u003cbr\u003e\u003ci\u003eLiying Cui, Mingsheng Liu\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e102 Acquired Neuropathies\u003cbr\u003e\u003ci\u003eFriedhelm Sandbrink\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e103 Plexopathies\u003cbr\u003e\u003ci\u003eFriedhelm Sandbrink\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 13 Neuromuscular Disorders\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eHereditary Neuromuscular Disorders\u003cbr\u003e\u003c\/i\u003e\u003cb\u003eDegenerative upper and lower motor neuron disorders\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e104 Amyotrophic Lateral Sclerosis (ALS)\u003cbr\u003e\u003ci\u003eBjörn Oskarsson, Nanette Joyce, Steven P. Ringel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e105 Progressive Muscular Atrophy (PMA)\u003cbr\u003e\u003ci\u003eJames Ha, Steven P. Ringel, Björn Oskarsson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e106 Primary Lateral Sclerosis (PLS)\u003cbr\u003e\u003ci\u003eNanette Joyce, Björn Oskarsson, Yvonne D. Rollins, Steven P. Ringel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e107 Hereditary spastic paraplegia\u003cbr\u003e\u003ci\u003eIldefonso Rodríguez-Leyva\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e108 Spinal muscular atrophy\u003cbr\u003e\u003ci\u003eSabine Rudnik-Schöneborn, Klaus Zerres\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e109 Post-polio syndrome\u003cbr\u003e\u003ci\u003eNils Erik Gilhus\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eDegenerative Muscle Disorders\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e110 Limb girdle muscular dystrophies (LGMD)\u003cbr\u003e\u003ci\u003eA. J. van der Kooi, M. de Visser\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e111 Dystrophinopathies\u003cbr\u003e\u003ci\u003eChiara S. M. Straathofa, Marianne de Visserb\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e112 Facioscapulohumeral dystrophy (FSHD)\u003cbr\u003e\u003ci\u003eGeorge W. Padberg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e113 Myotonic disorders\u003cbr\u003e\u003ci\u003eGiovanni Meola, Rosanna Cardani\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e114 Oculopharyngeal Muscular Dystrophy (OPMD)\u003cbr\u003e\u003ci\u003eLuis A. Chui, Tahseen Mozaffar, Namita A. Goyal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e115 Emery Dreifuss and other laminopathies\u003cbr\u003e\u003ci\u003eMalcolm Rabie, Yoram Nevo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e116 Muscle channelopathies\u003cbr\u003e\u003ci\u003eKaren Suetterlin, Michael G. Hanna\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e117 Congenital dystrophies and myopathies\u003cbr\u003e\u003ci\u003eYoung-Chul Choi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e118 Congenital myasthenic syndromes (CMS)\u003cbr\u003e\u003ci\u003eAngela Abicht, Ulrike Schara\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e119 Distal myopathies\u003cbr\u003e\u003ci\u003ePhillipa J. Lamont, Nigel G. Laing\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eAcquired Neuromuscular Disorders\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e120 Polymyositis\u003cbr\u003e\u003ci\u003eMarinos C. Dalakas\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e121 Dermatomyositis\u003cbr\u003e\u003ci\u003eMarinos C. Dalakas\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e122 Inclusion body myositis (IBM)\u003cbr\u003e\u003ci\u003eMerrilee Needham, Frank L. Mastaglia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e123 Immune mediated inflammatory myopathies\u003cbr\u003e\u003ci\u003eWerner Stenzel, Hans-Hilmar Goebel, Olivier Benveniste, Yves Allenbach\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e124 Toxic myopathies\u003cbr\u003e\u003ci\u003eStefen Brady, David Hilton-Jones\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e125 Critical illness neuromuscular disorders\u003cbr\u003e\u003ci\u003eNicola Latronico, Frank A. Rasulo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e126 Exercise intolerance and myoglobinuria\u003cbr\u003e\u003ci\u003eJohn Vissing\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e127 Muscle cramps\u003cbr\u003e\u003ci\u003eKimiyoshi Arimura, Raymond L. Rosales\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e128 Myasthenia gravis\u003cbr\u003e\u003ci\u003eRichard A. Lewis\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e129 LEMS\u003cbr\u003e\u003ci\u003eEmilia Kerty\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e130 NMJ disorders caused by drugs and toxins\u003cbr\u003e\u003ci\u003eZohar Argov\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 14 Neurogenetic\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e131 Neurogenetic\u003cbr\u003e\u003ci\u003eKaren P. Frei, Janice Fuentes\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 15 Neurootology\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e132 Neurootology\u003cbr\u003e\u003ci\u003eKevin A. Kerber\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 16 Neuroophthalmology\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e133 Neuroophthalmology\u003cbr\u003e\u003ci\u003eAnuchit Poonyathalang\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 17 Neuro-oncology\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e134 Neuro-oncology overview\u003cbr\u003e\u003ci\u003eMarc C. Chamberlain\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eGlial tumors\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e135 High grade astrocytomas\u003cbr\u003e\u003ci\u003eOlivier-L Chinot, Marc C. Chamberlain\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e136 Low grade astrocytomas\u003cbr\u003e\u003ci\u003eM.J. van den Bent\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e137 Low grade and anaplastic oligodendroglioma\u003cbr\u003e\u003ci\u003eSergio Cabrera, Catherine Maurice, Warren P. Mason\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e138 Brain stem glioma\u003cbr\u003e\u003ci\u003eIra J. Dunkel, Mark M. Souweidane\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e139 Intracranial ependymoma\u003cbr\u003e\u003ci\u003eMarc C. Chamberlain\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eNon-glial tumors\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e140 Nerve sheath tumors\u003cbr\u003e\u003ci\u003eNathan J. Ranalli, Zarina S. Ali, Gregory G. Heuer, Eric L. Zager\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e141 Meningiomas\u003cbr\u003e\u003ci\u003eJeffrey Raizer, Simran Singh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e142 Medulloblastoma\u003cbr\u003e\u003ci\u003eAlba A. Brandes, Regina I. Jakacki, Enrico Franceschi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e143 Primary central nervous system lymphoma (PCNSL)\u003cbr\u003e\u003ci\u003eDeborah T. Blumenthal, Idan Ben-Horin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eMetastatic tumors\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e144 Brain metastases\u003cbr\u003e\u003ci\u003eBabita Jyoti, Farida Balkhi Alam, Silvia Hofer, Michael Brada\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e145 Leptomeningeal metastases\u003cbr\u003e\u003ci\u003eEmilie Le Rhun, Sophie Taillibert, Marc C. Chamberlain\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e146 Spinal epidural metastases\u003cbr\u003e\u003ci\u003eRoberta Rudà, Riccardo Soffietti\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eNeurologic complications of systemic cancer\u003cbr\u003e147 General approach to the diagnosis and treatment of paraneoplastic neurological disorders\u003cbr\u003e\u003ci\u003eMyrna R. Rosenfeld, Josep Dalmau\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 18 Sleep disorders\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e148 Insomnia\u003cbr\u003e\u003ci\u003eDelwyn J. Bartlett, Colin A. Espie\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003ePrimary disorders of daytime somnolence\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e149 Narcolepsy\u003cbr\u003e\u003ci\u003eMarcel Hungs\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e150 Idiopathic hypersomnia\u003cbr\u003e\u003ci\u003eMarcel Hungs\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e151 Obstructive Sleep Apnea\u003cbr\u003e\u003ci\u003eJanesh Patel, Christian Guilleminault\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e152 Restless Leg syndrome and Periodic Limb Movement Disorders\u003cbr\u003e\u003ci\u003eBirgit Högl, Birgit Frauscher, Claudio Podesta\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e153 Circadian sleep disorders\u003cbr\u003e\u003ci\u003eSergio Tufik, Lia R .A. Bittencourt, Monica L. Andersen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eParasomnias\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e154 Arousal disorders\u003cbr\u003e\u003ci\u003eLi Ling Lim\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e155 REM Sleep Behavioral Disorders\u003cbr\u003e\u003ci\u003eLi Ling Lim\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e156 Hypnogenic paroxysmal Dystonia\u003cbr\u003e\u003ci\u003eCynthia L. Comella\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e157 Sleep abnormalities in Neurological Disorders\u003cbr\u003e\u003ci\u003eMargaret Park, Cynthia L. Comella\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 19 Spinal cord\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e158 Spinal cord disorders\u003cbr\u003e\u003ci\u003eDavid B. Vodušek, Miran Jeromel, Simon Podnar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e159 Ischemic and congestive myelopathies\u003cbr\u003e\u003ci\u003eSimon Podnar, Miran Jeromel, David B. Vodušek\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e160 Syringomyelia\u003cbr\u003e\u003ci\u003eAlla Guekht\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 20 Pediatric neurology\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e161 Neonatal neurology\u003cbr\u003e\u003ci\u003eMary Payne, Ann Tilton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e162 Neurodevelopmental disorders\u003cbr\u003e\u003ci\u003eAdam L. Numis, Raman Sankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e163 Floppy infant syndrome\u003cbr\u003e\u003ci\u003eJong-Hee Chae, Anna Cho\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e164 Storage disorders\u003cbr\u003e\u003ci\u003eJeffrey J. Ekstrand, Jason T. Lerner, Raman Sankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e165 Fatty acid oxidation disorders\u003cbr\u003e\u003ci\u003eThomas Wieser\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e166 Disorders of amino acid, organic acid, and ammonia metabolism\u003cbr\u003e\u003ci\u003eStephen Cederbaum\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e167 Pediatric neurotransmitter diseases\u003cbr\u003e\u003ci\u003eStephen Deputy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e168 Mitochondrial encephalomyopathies\u003cbr\u003e\u003ci\u003eStacey K. H. Tay, Caterina Garone, Salvatore DiMauro\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e169 Disorders resulting from transporters\u003cbr\u003e\u003ci\u003eAnna Czlonkowska, David Gloss, Tomasz Litwin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e170 The porphyrias\u003cbr\u003e\u003ci\u003eF. J. E. Vajda\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 21 CNS Trauma, Pain and Headache\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e171 Traumatic brain injury\u003cbr\u003e\u003ci\u003eChristopher C. Giza\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e172 Spinal Injury\u003cbr\u003e\u003ci\u003eEnver I. Bogdanov, Aisylu T. Faizutdinova\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e173 Whiplash injury\u003cbr\u003e\u003ci\u003eAnthony Ciabarra\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e174 Decompression sickness\u003cbr\u003e\u003ci\u003eAndreas Koch, Günther Deuschl\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e175 Pain\u003cbr\u003e\u003ci\u003eGuillermo García-Ramos, Bernardo Cacho-Díaz, Bruno Estañol-Vidal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e176 Headache\u003cbr\u003e\u003ci\u003eStephen D. Silberstein\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e177 Facial and neck pain\u003cbr\u003e\u003ci\u003eKammant Phanthumchinda\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e178 Chronic Fatigue Syndrome\u003cbr\u003e\u003ci\u003eJasem Yousef Al-Hashel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e179 Fibromyalgia\u003cbr\u003e\u003ci\u003eSaeed Bohlega, Hussam Abou Al-Shaar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex\u003c\/p\u003e \u003cp\u003e\u003cb\u003eROBERT P. LISAK, FAAN, FRCP (E), FANA\u003cbr\u003e\u003c\/b\u003eParker Webber Chair in Neurology, Professor of Neurology, Professor of Immunology and Microbiology, Wayne State University School of Medicine; Attending Neurologist, Detroit Medical Center, Detroit, MI, USA\u003c\/p\u003e \u003cp\u003e\u003cb\u003eDANIEL D. TRUONG MD FAAN\u003cbr\u003e\u003c\/b\u003eThe Truong Neuroscience Institute, Orange Coast Memorial Medical Center, Fountain Valley, CA, USA; Professor, University California Riverside, Riverside, CA, USA\u003c\/p\u003e \u003cp\u003e\u003cb\u003eWILLIAM M. CARROLL MBBS MD FRACP FRCP(E)\u003cbr\u003e\u003c\/b\u003eClinical Professor of Neurology, Western Australian Research Institute, University of Western Australia, Australia\u003c\/p\u003e \u003cp\u003e\u003cb\u003eROONGROJ BHIDAYASIRI MD FRCP\u003cbr\u003e\u003c\/b\u003eDirector, Chulalongkorn Comprehensive Movement Disorders Center\u003cbr\u003eChulalongkorn University Hospital, Bangkok, Thailand;\u003cbr\u003eUniversity of California at Los Angeles, Los Angeles, CA, USA\u003c\/p\u003e \u003cp\u003eThe second edition of this unique text for clinical neurology provides an expanded picture on the variation of neurological disease across the world. As the field of neurology develops there is a need for clinicians to keep abreast of global trends and patterns. Most texts consider only Western populations and miss many of the variations that are present in modern, mixed heritage communities and as such, the wrong models of causation can be applied, leading to insufficient diagnosis and ineffective management. Equally, the increase in international travel has made it more likely that patients present to physicians with diseases they have not yet seen, or with different manifestations of diseases they have seen.\u003c\/p\u003e \u003cp\u003eThis book is written by an extensive team of authors and section editors from across the world, familiar with, and expert in, neurologic diseases. The chapters address the etiology and pathogenesis of disease, and then discuss differences in genetic, environmental, and demographic factors, as well as therapeutic approaches from an evidence-based medicine approach. Coverage of management options describes both the ‘gold' standard that may be present in Western countries, and other more affordable, approaches for developing nations.\u003c\/p\u003e \u003cp\u003eAcross 21 sections and 179 chapters, the book provides essential content on the spectrum of neurological diseases and disorders emphasizing, where present, differences in diseases and their manifestations in different populations and locales. Varying approaches to differential diagnoses around the world and is also covered.\u003c\/p\u003e \u003cul\u003e \u003cli\u003eComprehensive coverage of neurological diseases and disorders with a clinical approach to diagnosis, treatment and management\u003c\/li\u003e \u003cli\u003eTruly international authorship distils expert knowledge from around the world\u003c\/li\u003e \u003cli\u003eSuccinct, bite-sized, templated chapters allow for rapid clinical referral\u003c\/li\u003e \u003cli\u003eFurther reading recommendations for each chapter guide readers requiring more depth of information\u003c\/li\u003e \u003cli\u003eEndorsed by the World Federation of Neurology\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eThis uniquely global approach to neurology provides an outstanding teaching tool and guide to clinical practice around the world for neurologists and neurology trainees.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989448016101,"sku":"NP9781118777367","price":280.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781118777367.jpg?v=1761784138","url":"https:\/\/k12savings.com\/es\/products\/international-neurology-isbn-9781118777367","provider":"K12savings","version":"1.0","type":"link"}